New Delhi, March 6 (SocialNews.XYZ) High base effect along with volume decline subdued the growth of India's pharmaceuticals market, India Ratings and Research (Ind-Ra) said.
Accordingly, the volume declined in the anti-infective and respiratory products was pronounced during the month.
"Ind-Ra expects a growth improvement over the coming months as the vaccination drive gains momentum and a lower base leads to better growth momentum."
"However, IPM grew 1.1 per cent YoY during February 2021, due to a 5.8 per cent volume decline, price growth of 4.8 per cent and products launches at 2.1 per cent."
According to Ind-Ra, acute therapies such as gastro and vitamins witnessed sales growth of 9.9 per cent YoY and 8.6 per cent YoY, respectively, while anti-infectives declined 11.3 per cent YoY during February 2021.
"A growth outperformance was observed in chronic therapies during the month, with cardiac and anti-diabetic growing 7.3 per cent YoY and 4.3 per cent YoY, respectively."
Source: IANS
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz
This website uses cookies.
